Patient adherence in COPD

Cited by (489)

Items 201–300 of 489

1. A Pharmacy-Based eHealth Intervention Promoting Correct Use of Medication in Patients With Asthma and COPD: Nonrandomized Pre-Post Study
   Kyma Schnoor, Anke Versluis, Robbert Bakema, Sanne van Luenen, Marcel J. Kooij, Jan Maurik van den Heuvel, Martina Teichert, Persijn Honkoop, Job F. M. van Boven, Niels Henrik Chavannes et al. · 2022 · Journal of Medical Internet Research
2. Indian Guidelines on Nebulization Therapy
   S K Katiyar, Shailendra N. Gaur, RN Solanki, Nikhil Sarangdhar, Jagdish Chander Suri, Raj Kumar, GC Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz Ahmad Koul et al. · 2022 · Indian Journal of Tuberculosis
3. Clinical diaries in COPD: compliance and utility in predicting acute exacerbations
   Richard R Wood-Baker, Eugene Haydn Walters, Andrew Robinson, Eugene Haydn Walters, Karen E. Wills · 2012 · International Journal of COPD
4. Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD
   Katharina Marth, Elisabeth Schuller, Wolfgang Pohl · 2015 · Respiratory Medicine
5. Telemedicine for patients with COPD: new treatment approaches to improve daily activity behaviour
   Monique Tabak · 2014
6. Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison
   Shannon F. Cope, Gorana Capkun-Niggli, Rupert Gale, Cheryl Lassen, Roger J. Owen, Mario Ouwens, Gert Bergman, Jeroen Paul Jansen · 2012 · Value in Health
7. What distinguishes clinicians who better support patients for chronic disease self-management?
   Sue E. Kirby, Sarah May Dennis, Pat Bazeley, Mark Harris · 2011 · Australian Journal of Primary Health
8. Arterial and Venous Thromboembolism in Chronic Obstructive Pulmonary Disease: From Pathogenic Mechanisms to Prevention and Treatment
   Filip Mejza, Bernd Lamprecht, Ewa Niżankowska‐Mogilnicka, Anetta Undas · 2015 · Advances in respiratory medicine
9. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)
   Andreas Clemens, José María Marín, Kai Michael Beeh, Walter Castellani, Lennart Schaper, Dinesh Saralaya, Anthony Gunstone, Ricard Casamor, Κonstantinos Κostikas, Maryam Aalamian‐Mattheis · 2016 · International Journal of COPD
10. Patient education during hospital admission due to exacerbation of chronic obstructive pulmonary disease: Effects on quality of life—Controlled and randomized experimental study
    Ana Folch Ayora, María Isabel Orts‐Cortés, L. Macia-Soler, M.V. Andreu-Guillamon, Joaquín Moncho Vasallo · 2018 · Patient Education and Counseling
11. Adherence to home-based inspiratory muscle training in individuals with chronic obstructive pulmonary disease
    Dorthe Sørensen, Helle Svenningsen · 2018 · Applied Nursing Research
12. Predictors of patient adherence to COPD self-management exacerbation action plans
    Jade Schrijver, Tanja Effing, Marjolein G J Brusse-Keizer, Job A.M. van der Palen, Paul D.L.P.M. VanderValk, Anke Lenferink · 2020 · Patient Education and Counseling
13. Current Status and Influencing Factors of Readiness for Discharge of Elderly Patients with Chronic Obstructive Pulmonary Disease
    Dao-Lin Wu, Chun-Li Luo, Xu Du, Pei-Pei Li, Min Jiang, Tao Liu, Yun Sun · 2023 · Patient Preference and Adherence
14. Self-reported inhaler use in patients with chronic obstructive pulmonary disease
    Kory VanderSchaaf, Kari L. Olson, Sarah J. Billups, Cynthia L. Hartsfield, Melissa A. Rice · 2009 · Respiratory Medicine
15. Medication non-adherence as a cause of hospital admissions.
    Miriam Álvarez Payero, N Martínez López de Castro, M. Ucha Samartín, A Martín Vila, Cristina Vázquez, Guadalupe Piñeiro Corrales · 2014 · PubMed
16. Usage and Usability of One Dry Powder Inhaler Compared to Other Inhalers at Therapy Start: An Open, Non-interventional Observational Study in Poland and Germany
    Piotr Hantulik, Karola Wittig, Yvonne Henschel, Joachim Ochse, Mikko Vahteristo, Paula H. Rytilä · 2015 · Advances in respiratory medicine
17. Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease
    Rajiv Dhand, Tricia Cavanaugh, NEIL SKOLNIK · 2018 · Cleveland Clinic Journal of Medicine
18. Optimizing safety of COPD treatments: role of the nurse practitioner
    Pamela Spencer, Nicola Alexander Hanania · 2013 · Journal of Multidisciplinary Healthcare
19. Day and Night Control of COPD and Role of Pharmacotherapy: A Review
    Alberto Braghiroli, Fulvio Braido, Alessio Piraino, Paola Rogliani, Pierachille Santus, Nicola Scichilone · 2020 · International Journal of COPD
20. An expert‐supported monitoring system for patients with chronic obstructive pulmonary disease in general practice: results of a cluster randomised controlled trial
    Lisette van den Bemt, Tjard R. Schermer, Ivo J M Smeele, Leandra J M Boonman‐de Winter, Ton J. van Boxem, Joke Denis, Joke Grootens, Richard P.T.M. Grol, Chris van Weel · 2009 · The Medical Journal of Australia
21. Smoking Cessation Interventions for COPD: A Review of the Literature
    Renata Pires-Yfantouda, Gareth Absalom, Felicity Clemens · 2013 · Respiratory Care
22. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects
    Gregory Feldman, Anton Edin · 2013 · Therapeutic Advances in Respiratory Disease
23. Patients’ and their caregivers’ experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study
    Diana H. Ferreira, Slavica Kochovska, Aaron Honson, Jane Louise Phillips, David C. Currow · 2022 · BMJ Open Respiratory Research
24. Clinical use of aclidinium in patients with COPD
    Debra J. Reid, Alexa A. Carlson · 2014 · International Journal of COPD
25. A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI
    Suyong Yun Kirby, Chang‐Qing Zhu, Edward Kerwin, Richard H. Stanford, George C. Georges · 2015 · COPD Journal of Chronic Obstructive Pulmonary Disease
26. Medication Compliance in COPD Patients
    Jacek Polański, Mariusz Chabowski, Natalia Świątoniowska-Lonc, Grzegorz J. Mazur, Beata Jankowska‐Polańska · 2020 · Advances in experimental medicine and biology
27. Accuracy of Inhaler Use in Patients With Chronic Obstructive Pulmonary Disease
    Haejung Lee, Sunjoo Boo, Yeonjung Lim, Sung-Min Kim, Inah Kim · 2013 · Clinical Nursing Research
28. “Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study – The TRIBUNE study”
    Κonstantinos Porpodis, Κonstantinos Bartziokas, Panagiotis Chatziapostolou, Aliki Korkontzelou, Panos Katerelos, Petros Efstathopoulos, Petros Bakakos · 2023 · Respiratory Medicine
29. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting
    Suzanne G. Bollmeier, Terry Seaton, Theresa R. Prosser, Yi-Ting Chou, Kristine Reckenberg, Beth A. Hahn, Richard H. Stanford, Riju Ray · 2019 · Journal of the American Pharmacists Association
30. Factors Influencing Self-Management of Chronic Obstructive Pulmonary Disease by Community-Dwelling Adults
    Wendy S. Bauer, Rachel F. Schiffman · 2019 · Western Journal of Nursing Research
31. Potential benefits of integrated COPD management in primary care
    Annemarije L. Kruis, Niels Henrik Chavannes · 2016 · Monaldi Archives for Chest Disease
32. Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD
    Lorraine Murphy, Stephen I. Rennard, James F. Donohue, Mathiéu Molimard, Ronald Dahl, Kai Michael Beeh, Juergen Dederichs, Hans‐Jürgen Fülle, Mark Higgins, David Young · 2014 · Drugs
33. Development and clinical gains of nurse-led medication monitoring profiles
    Marie Gabe, Sue E. Jordan · 2013 · Journal of Nursing Management
34. Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial
    Claudia Gregoriano, Thomas Dieterle, Selina Dürr, Isabelle Arnet, Kurt E. Hersberger, Jörg D. Leuppi · 2017 · JMIR Research Protocols
35. The Utility of Electronic Inhaler Monitoring in COPD Management
    Amy Houghton Attaway, Khaled Alshabani, Bruce G. Bender, Umur Sevket Hatipoglu · 2020 · CHEST Journal
36. Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease
    Claus Franz Vogelmeier, HELGO MAGNUSSEN, Craig LaForce, Roger J. Owen, Benjamin Krämer · 2011 · Therapeutic Advances in Respiratory Disease
37. Interactive Monitoring Service and COPD: Is it Possible to Reduce Nonadherence?
    Francesco Blasi, Federica Raddi, Marc Miravitlles · 2014 · COPD Journal of Chronic Obstructive Pulmonary Disease
38. Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire
    Takayuki Toyama, Tomotaka Kawayama, Takashi Kinoshita, Yohei Imamura, Makoto Yoshida, Koichiro Takahashi, Kazuhiko Fujii, Ikkou Higashimoto, Tomoaki Hoshino · 2018 · Internal Medicine
39. Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
    Sally D. Worsley, Neil G. Snowise, David M.G. Halpin, Dawn Midwinter, Afisi Ismaila, Elaine A Irving, Leah B. Sansbury, Maggie M Tabberer, David A. Leather, Chris H. Compton · 2019 · ERJ Open Research
40. Effects of person‐centred care via telephone on self‐efficacy in patients with chronic obstructive pulmonary disease: Subgroup analysis of a randomized controlled trial
    Lilas Ali, Sara Wallström, Inger Ekman, Karl B Swedberg, Andreas Fors · 2020 · Nursing Open
41. Factors affecting healthcare pathways for chronic lung disease management in Vietnam: a qualitative study on patients’ perspectives
    Thu Anh Nguyen, Yen Ngoc Pham, Nhung Doan Phuong, Thao Huong Nguyen, Đỗ Thị Thanh Toàn, Giap Van Vu, Guy Barrington Marks, Shannon McKinn, Joel Negin, Sarah Bernays et al. · 2021 · BMC Public Health
42. Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease
    Yohei Imamura, Tomotaka Kawayama, Takashi Kinoshita, Yuki Sakazaki, Makoto Yoshida, Koichiro Takahashi, Kazuhiko Fujii, Masaru Ando, Tomoaki Hoshino, Tomoaki Iwanaga et al. · 2016 · Allergology International
43. Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study
    Mónica Monteagudo, Montse Roset, Teresa Rodríguez-Blanco, Laura Muñoz, Marc Miravitlles · 2017 · International Journal of COPD
44. Clinic Appointment Attendance in Adults with Serious Mental Illness and Diabetes
    Douglas David Gunzler, Nathan J. Morris, Jarrod E. Dalton, Richard McCormick, Neal V. Dawson, Charles L. Thomas, Stephanie W. Kanuch, Kristin A. Cassidy, Melanie Athey, Edna Fuentes‐Casiano et al. · 2017 · American Journal of Health Behavior
45. Reducing COPD readmissions through predictive modeling and incentive-based interventions
    Xiang Zhong, Sujee Lee, Cong Zhao, Hyo Kyung Lee, Philip A. Bain, Tammy Kundinger, Craig Sommers, Christine Baker, Jingshan Li · 2017 · Health Care Management Science
46. A literature review on breathing retraining as a self-management strategy operationalized through Rosswurm and Larrabee's evidence-based practice model
    Lynda Facchiano, Charlene Hoffman‐Snyder, Diane Nunez · 2011 · Journal of the American Academy of Nurse Practitioners
47. Clinical characteristics and outcomes of polypharmacy in chronic obstructive pulmonary disease patients: A cross‐sectional study from Crete, Greece
    Despo Ierodiakonou, Erotokritos Theodorou, Dimitra I. Sifaki-Pistolla, Izolde Bouloukaki, Maria Antonopoulou, Ioannis Poulorinakis, Nikolaos Tsakountakis, Filothei Voltiraki, Konstantinos Chliveros, Ioanna Tsiligianni · 2021 · The Clinical Respiratory Journal
48. Ease-of-use, preference, confidence, and satisfaction with Revolizer ® , a novel dry powder inhaler, in an Indian population
    Sujeet K. Rajan, Jaideep A. Gogtay · 2014 · Lung India
49. Bronchodilator Efficacy of Single Doses of Indacaterol in Japanese Patients with COPD: A Randomised, Double-Blind, Placebo-Controlled Trial
    Motokazu Kato, Hironi Makita, Koji Uemura, Yoshinosuke Fukuchi, Motoi Hosoe, Charlotte Emery, Mark Higgins, Benjamin Krämer · 2010 · Allergology International
50. Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care
    Shahrzad Mohammadzadeh Lari, Davood Attaran, Mohammad Reza Tohidi · 2014 · Patient Related Outcome Measures
51. Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data
    Corinne Young, Lydia Lee, Kristi DiRocco, Guillaume Germain, J. Klimek, François Laliberté, Dominique Lejeune, Stephen G. Noorduyn, Rosirene Paczkowski · 2024 · Advances in Therapy
52. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
    Alexandru Corlăteanu, Serghei Covanţev, Olga Iasabash, Liliana Lupu, Mihaela Avadanii, Nikolaos Siafakas · 2025 · Healthcare
53. Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team
    Alpesh Amin, Sharon D. Cornelison, Joseph Andrew Woods, Nicola Alexander Hanania · 2021 · Postgraduate Medicine
54. Comparison of the clinical features and outcomes in two age-groups of elderly patients with atrial fibrillation
    Xing‐hui Shao, Yanmin Yang, Jun Zhu, Han Zhang, Yao Z. Liu, Xin Gao, Litian Yu, Lisheng Liu, Li Zhao, Peng-Fei Yu et al. · 2014 · Clinical Interventions in Aging
55. Is ‘GOLD’ standard for the management of COPD in clinical practice?
    Barbara P. Yawn · 2012 · Drugs in Context
56. Adherence to COPD free triple inhaled therapy in the real world: a primary care based study
    Alberto Zucchelli, Davide Liborio Vetrano, Elisa Bianchini, Francesco Paolo Lombardo, Alessio Piraino, Marco Zibellini, Alberto Rícci, Alessandra Marengoni, Francesco Lapi, Claudio Alberto Cricelli · 2020 · The Clinical Respiratory Journal
57. ATTACHED, DETACHED and WITHOUT inhaler technique coaching tools to optimize pMDI use competence, asthma control and quality-of-life in asthmatic adults
    Wesam G. Ammari, Nathir M. Obeidat, Abed Rahman Anani, Reem J. AlKalbani, Mark Sanders · 2020 · Journal of Thoracic Disease
58. Two Interventions for Patients with Major Depression and Severe Chronic Obstructive Pulmonary Disease: Impact on Dyspnea-Related Disability
    Alexopoulos, George S., Sirey, Jo Anne, Banerjee, Samprit, Jackson, Danielle S., Kiosses, Dimitris N., Pollari, Cristina, Novitch, Richard S., Artis, Amanda, Raue, Patrick J. · 2018 · The American Journal of Geriatric Psychiatry
59. Impact of Pharmacist-Led Intervention on Adherence to Inhalers, Inhalation Technique, and Disease Control Among Asthma/COPD Patients in a Resource Limited Center: An Interventional Study
    Ashika Bhattarai, Rajani Shakya, Durga Bista · 2024 · Patient Preference and Adherence
60. Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
    Wijdan H. Ramadan, Wissam K. Kabbara, Ghada El Khoury, Sarah Al-Assir · 2015 · International Journal of COPD
61. Comparative efficacy of indacaterol in chronic obstructive pulmonary disease
    Kenneth R. Chapman, Marcos Samuel Matias Ribeiro · 2012 · International Journal of COPD
62. Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease
    Laurent Laforest, Idlir Licaj, Gilles Devouassoux, Susanne Hartwig, Serge Marvalin, Eric H. Van Ganse · 2012 · Chronic Respiratory Disease
63. Indacaterol/glycopyrronium: a dual bronchodilator for COPD
    Donald D. Banerji, Robert Fogel, Francesco Patalano · 2017 · Drug Discovery Today
64. A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
    Wei‐Chun Huang, Chih‐Yu Chen, Wei-Chih Liao, Biing‐Ru Wu, Wei‐Chun Chen, Chih‐Yen Tu, Chia‐Hung Chen, Wen‐Chien Cheng · 2021 · International Journal of COPD
65. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
    Agnieszka Śliwka, Miłosz Jankowski, Iwona Gross‐Sondej, Monika Storman, Roman Nowobilski, Małgorzata Maria Bała · 2018 · Cochrane Database of Systematic Reviews
66. Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians
    Barbara P. Yawn · 2011 · International Journal of General Medicine
67. Étude observationnelle sur l’adhésion précoce aux traitements hypotonisants anti-glaucomateux
    Manon Belhassen, Laurent Laforest, Idlir Licaj, Eric H. Van Ganse · 2016 · Therapies
68. Elderly polypharmacy patients’ needs and concerns regarding medication assessed using the structured patient-pharmacist consultation model
    Sandra Vezmar Kovačević, Branislava Miljković, Katarina M. Vučićević, Milica Ćulafić, Milena Kovačević, Bojana Golubović, Marija Jovanović, J.J. de Gier · 2017 · Patient Education and Counseling
69. Non-adherence to COPD medications and its association with adverse events: A longitudinal population based cohort study of older adults
    Daniala L. Weir, Yu Bai, Kednapa Thavorn, Sara J. T. Guilcher, Salmaan Kanji, Sunita Mulpuru, Walter P. Wodchis · 2023 · Annals of Epidemiology
70. Effect of pneumonia on the outcomes of acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Fangbin Zheng, Xuqin Wang · 2024 · BMC Pulmonary Medicine
71. Bronchodilator efficacy and safety of indacaterol 150 µg once daily in patients with COPD: an analysis of pooled data
    Michelle Thorpe · 2011 · International Journal of COPD
72. Ligand-receptor binding kinetics in drug design
    D.V. Borisov, Alexander V. Veselovsky · 2020 · Biomeditsinskaya Khimiya
73. The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
    Deepak Talwar, Rudra Ramanathan, Meena Lopez, Rashmi Hegde, Jaideep A. Gogtay, Geeta Goregaonkar · 2021 · Lung India
74. Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population
    Tereza Hendrychova, Michal Svoboda, Josef Malý, Jiřı́ Vlček, Eva Zimčíková, Tomáš Dvořák, Jaromír Zatloukal, Eva Voláková, Marek Plutinský, Kristián Brat et al. · 2022 · Frontiers in Pharmacology
75. Complexity of Medication Use in Newly Diagnosed Chronic Obstructive Pulmonary Disease Patients
    Caitlyn T. Solem, Todd A. Lee, Min J. Joo, Bruce L. Lambert, Surrey M. Walton, Alan Simon Pickard · 2012 · The American Journal of Geriatric Pharmacotherapy
76. Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
    Erminia Ridolo, Montagni, Elisa Olivieri, Riario-Sforza, Cristoforo Incorvaia · 2013 · International Journal of COPD
77. Effect of patient education on adherence to drug treatment for chronic obstructive pulmonary disease
    Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza · 2011 · Annals of Thoracic Medicine
78. Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
    Anthony D D’Urzo, Péter Kardos, Russell Wiseman · 2018 · International Journal of COPD
79. Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
    Kirsten Koehorst-ter Huurne, Marjolein G J Brusse-Keizer, Paul van der Valk, Kris L. L. Movig, Job A.M. van der Palen, Christina Bode · 2018 · Patient Preference and Adherence
80. A QUALITATIVE STUDY OF PERSPECTIVES, EXPECTATIONS AND NEEDS OF EDUCATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Rifaatul Laila Mahmudah, Zullies Ikawati, Djoko Wahyono · 2016 · International Journal of Current Pharmaceutical Research
81. The Association Between Medication Adherence and Health-Related Quality of Life in Patients with COPD: A Cross-Sectional Study
    Saja, Maha, Younis, Afnan, Alzahrani, Lamiss, Alkhlassi, Ibtisam, Aldakhil, Lama, Albayyat, Rawan, Alnasser, Noura, Alokla, Khalid, Alghamdi, Lamia, Rashed, Albatol et al. · 2025 · International Journal of Chronic Obstructive Pulmonary Disease
82. Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
    Meredith C. McCormack, Rosirene Paczkowski, Noelle N. Gronroos, Stephen G. Noorduyn, Lydia Lee, Sreenivas P. Veeranki, Mary G. Johnson, Emmeline Igboekwe, Kristin Kahle‐Wrobleski, Reynold A. Panettieri · 2024 · Advances in Therapy
83. Educational and supportive interventions for improving adherence to inhalation therapy in people with chronic respiratory diseases: A systematic review protocol
    Ka Wing To, Wai Man Lee, Kai Chow Choi, Doris Sau Fung Yu, Janita Pak Chun Chau, Iris Lee · 2013 · The JBI Database of Systematic Reviews and Implementation Reports
84. “It’s a lonely battle”: A qualitative study of older adult Canadians’ experiences with chronic obstructive pulmonary disease medication adherence and support
    Leanne Skerry, Emily K. Kervin, Tracy A. Freeze, Andrew Brillant, Jennifer Woodland, Natasha E. Hanson · 2022 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
85. Cost-related medication nonadherence in adults with COPD in the United States 2013–2020
    Xin Wen, Hongbin Qiu, Bo Yu, Jinfeng Bi, Xia Gu, Yiying Zhang, Shanjie Wang · 2024 · BMC Public Health
86. Seventeen‐Year Nationwide Trends in Use of Long‐acting Bronchodilators and Inhaled Corticosteroids among Adults – A Danish Drug Utilization Study
    Mette Reilev, Anton Pottegård, Jesper Rømhild Davidsen, Lotte Rasmussen, Jens Søndergaard, Christian Borbjerg Laursen, Daniel Pilsgaard Henriksen · 2018 · Basic & Clinical Pharmacology & Toxicology
87. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand
    Xiaomeng Xu, Dominique Milea, Aldo Amador Navarro Rojas, Anthony Braganza, Tim Holbrook, Brett Marett, Robert Young, Raewyn J. Scott, Barry Gribben · 2021 · International Journal of COPD
88. The present and future of inhalation therapy for the management of obstructive airway diseases: Emphasis on pressurized metered-dose inhalers
    Paschalis Steiropoulos, Petros Bakakos, Elpis Hatziagorou, Paraskevi A Katsaounou, Stelios Loukides, Andriana Ι. Papaioannou, Κonstantinos Porpodis, Κωνσταντίνος Σαμαράς, Argyrios Tzouvelekis, Konstantinos Kalafatakis et al. · 2021 · Pneumon
89. A Survey of Opinions and Attitudes Toward Exercise Following a 12-month Maintenance Exercise Program for People with COPD
    Lissa M. Spencer, Jennifer Ailsey Alison, Zoe Jane McKeough · 2013 · Cardiopulmonary Physical Therapy Journal
90. Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD
    Donald D. Banerji, Donald A. Mahler, Nicola Alexander Hanania · 2016 · Expert Review of Respiratory Medicine
91. Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application
    Jacob Sandberg, Robert Lansing, Peter Anderberg, David C. Currow, Josefin Sundh, Zainab Ahmadi, Sebastian Palmqvist, Magnus Per Ekström · 2019 · BMJ Open Respiratory Research
92. Combination of Fluticasone Furoate and Vilanterol for the Treatment of Chronic Obstructive Pulmonary Disease
    Suzanne G. Bollmeier, Theresa R. Prosser · 2013 · Annals of Pharmacotherapy
93. Which treatment for obstructive airway disease: The inhaled bronchodilators
    Fabio Perrotta, Filomena Mazzeo, Francesco Saverio Cerqua · 2017 · Pulmonary Pharmacology & Therapeutics
94. The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients
    Claudio Maria Sanguinetti · 2014 · Multidisciplinary Respiratory Medicine
95. Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis
    Marie Topp, Jørgen Vestbo, Erik Lykke Mortensen · 2016 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
96. A Clinical Perspective on the Role of Electronic Devices in Monitoring and Promoting Adherence in Airways Disease
    Vincent Brennan, Christopher Mulvey, Garrett Greene, Elaine MacHale, Richard W. Costello · 2021 · Frontiers in Medical Technology
97. The role of galenic innovation in improving treatment compliance and persistence: three case studies
    York Francis Zöllner, Balp, Andrea Gili Marco · 2011 · ClinicoEconomics and Outcomes Research
98. Strategies used by respiratory nurses to stimulate self‐management in patients with COPD
    Remco Verbrugge, Fijgje de Boer, Jean‐Jacques Georges · 2013 · Journal of Clinical Nursing
99. Indacaterol for the treatment of chronic obstructive pulmonary disease
    Maria Gabriella Matera, Paola Rogliani, Mario Cazzola · 2014 · Expert Opinion on Pharmacotherapy
100. Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education
     Claudio Maria Sanguinetti, Fernando De Benedetto, Claudio Ferdinando Donner, Stefano G. Nardini, Alberto Visconti · 2014 · Multidisciplinary Respiratory Medicine